| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000015057 |
| Receipt No. | R000017514 |
| Official scientific title of the study | Investigation of metabolic change by SGLT2 inhibitors in type 2 diabetes patients. |
| Date of disclosure of the study information | 2014/09/04 |
| Last modified on | 2017/11/26 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Investigation of metabolic change by SGLT2 inhibitors in type 2 diabetes patients.
|
|
| Title of the study (Brief title) | Metabolic change by SGLT2 inhibitors. | |
| Region |
|
|
| Condition | ||
| Condition | type 2 diabetes | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the metabolic change by SGLT2 inhibitors in type 2 diabetes patients. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Body composition
Glucose profile Nitrogen balance |
| Key secondary outcomes | Body weight
Glycated hemoglobin Glycated albumin Lipid profile Urinary albumin excretion Urinary protein excretion |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | SGLT2 inhibitors | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Men and women who were diagnosed with type 2 diabetes in the diagnostic criteria of the Japan Diabetes Society.
2. Patients determined to require hospitalization for education and diabetes management in Kitasato University Hospital of Endocrinology and Metabolism. 3. Patients who are considered treatment with SGLT2 inhibitors is suitable. 4. Patients who obtained informed consent. |
|||
| Key exclusion criteria | 1. severe ketosis, diabetic coma, or before coma
2. before and not long after surgery,or patients with severe trauma 3. alcohol intake's excessive 4. patients who have a fever of 37.0 degrees or more 5. obvious infection 6. severe renal dysfunction or dialysis patients 7. patients with symptoms of urinary retention, difficulty urinating, anuria, or oliguria 8. severe liver dysfunction 9. patients with obvious active malignant tumor 10. women suspected of pregnancy or pregnant 11. patients with a history of use SGLT2 inhibitors |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | TAKAHIRO YAMAGISHI |
| Organization | Kitasato University School of Medicine |
| Division name | Endocrinology and Metabolism |
| Address | 1-15-1,kitasato,minami-ku,sagamihara-city,kanagawa-ken,JAPAN |
| TEL | 042-778-8111 |
| yamagishi@med.kitasato-u.ac.jp | |
| Public contact | |
| Name of contact person | TAKAHIRO YAMAGISHI |
| Organization | Kitasato University School of Medicine |
| Division name | Endocrinology and Metabolism |
| Address | 1-15-1,kitasato,minami-ku,sagamihara-city,kanagawa-ken,JAPAN |
| TEL | 042-778-8111 |
| Homepage URL | |
| yamagishi@med.kitasato-u.ac.jp | |
| Sponsor | |
| Institute | Kitasato University School of Medicine,Endocrinology and Metabolism. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 北里大学病院(神奈川県)
Kitasato University Hospital |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000017514 |